The role of gut microbiota in the neurobiology and treatment of Alzheimer’s disease (Review)
Seyed Khalil Rashidi, Mitra Ansari Dezfouli, Hamidreza Khalili and Ali Kiani Deh Kiani
PCSK9 inhibitor Evolocumab alleviates atherosclerosis progression by suppressing endothelial cell injury via the ROS/MAPK pathway
Menghuai Ma, Fan Liu, Xiaomei Yin, Jianhong Yue, Yanhua Duan and Jiong Tang
The lncRNA SNHG9, an oncogenic regulator, stabilizes PRMT7 by binding to PTBP1 in the progression of colorectal cancer
Chengbai Liang
USP30 promotes cytarabine resistance in acute myeloid leukemia by deubiquitinating and stabilizing FOXM1
Yaxuan Jiang, Zhen Zhang, Huilin Shu, Ronghua Li, Zhongcui Zhang, Ben Ma and Yan Wang
lncRNA MEG3 promotes hypoxia/reoxygenation-induced ferroptosis and cell injury in H9C2 cells through regulating the miR-22/TP53 axis
Guangyu Ma, Hairui Jiang, Meina Li, Caijie Li and Ningning Zhang
Integrated evaluation of genetic and pharmacological RAGE inhibition reveals a multidimensional therapeutic strategy for diabetic atherosclerosis
Yongcong He, Fan Wu, Jun Lai, Zebing Ye and Jijin Lin
Determining the effects of SGLT2 inhibitor on breast cancer cell migration and clonogenicity – a pilot study
Vincent Lučanský, Ivana Baranová, Iryna Samec, Martin Jozef Péč, Renata Péčová and Marek Samec
© 2026 Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences